Table 3 Analysis of the Predictive Value was performed for a descriptive comparison between CHD5 expression and MYCN and 1p LOH.
From: Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
Overall Survival | Event Free Survival | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Alive | Dead | PPV | NPV | No event | Event | PPV | NPV | ||
CHD5 IHC | High | 27 (62.8%) | 1 (5%) | 54.30% | 96.40% | 24 (70.6%) | 4 (13.8%) | 71.40% | 85.70% |
Low | 16 (37.2%) | 19 (95%) | 10 (29.4%) | 25 (86.2%) | |||||
MYCN | Non amplified | 40 (93%) | 9 (60%) | 66.70% | 81.60% | 32 (94.1%) | 17 (70.8%) | 77.80% | 65.30% |
Amplified | 3 (7%) | 6 (40%) | 2 (5.9%) | 7 (29.2%) | |||||
1p LOH | No | 30 (78.9%) | 8 (53.3%) | 46.70% | 78.90% | 24 (80%) | 14 (60.9%) | 60% | 63.20% |
LOH | 8 (21.1%) | 7 (46.7%) | 6 (20%) | 9 (39.1%) | |||||